[HTML][HTML] Vascular calcification—new insights into its mechanism

SJ Lee, IK Lee, JH Jeon - International journal of molecular sciences, 2020 - mdpi.com
Vascular calcification (VC), which is categorized by intimal and medial calcification,
depending on the site (s) involved within the vessel, is closely related to cardiovascular …

[HTML][HTML] Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches

P Düsing, A Zietzer, PR Goody, MR Hosen… - Journal of molecular …, 2021 - Springer
Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney
disease (CKD). Both conditions are rising in incidence as well as prevalence, creating poor …

Effects of alloying elements on the corrosion behavior and biocompatibility of biodegradable magnesium alloys: a review

Y Ding, C Wen, P Hodgson, Y Li - Journal of materials chemistry B, 2014 - pubs.rsc.org
Magnesium (Mg) based alloys have been extensively considered for their use as
biodegradable implant materials. However, controlling their corrosion rate in the …

Vascular stiffness: its measurement and significance for epidemiologic and outcome studies

SS DeLoach, RR Townsend - … Journal of the American Society of …, 2008 - journals.lww.com
Arterial stiffness is recognized increasingly as an important component in the determination
of cardiovascular risk, particularly in chronic kidney disease and ESRD populations …

Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients

HJ Hsu, MS Wu - The American journal of the medical sciences, 2009 - Elsevier
Background Left ventricular hypertrophy (LVH) is a common cardiovascular disorder and an
independent risk factor for cardiovascular death in dialysis patients. Hyperphosphatemia is …

Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue

ND Toussaint, GJ Elder, PG Kerr - Clinical Journal of the American …, 2009 - journals.lww.com
Cardiovascular disease is highly prevalent in chronic kidney disease (CKD) and is often
associated with increased vascular stiffness and calcification. Recent studies have …

[HTML][HTML] The effects of warfarin and direct oral anticoagulants on systemic vascular calcification: a review

K Elango, A Javaid, BK Khetarpal, S Ramalingam… - Cells, 2021 - mdpi.com
Warfarin has been utilized for decades as an effective anticoagulant in patients with a history
of strong risk factors for venous thromboembolism (VTE). Established adverse effects …

Vascular calcification in end‐stage renal disease

KL Jablonski, M Chonchol - Hemodialysis International, 2013 - Wiley Online Library
Vascular calcification is highly prevalent in end‐stage renal disease and independently
predictive of future cardiovascular events and mortality. C alcification can occur in both the …

Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial

ND Toussaint, KK Lau, BJ Strauss… - American Journal of …, 2010 - Elsevier
BACKGROUND: Vascular calcification contributes to cardiovascular disease in patients with
chronic kidney disease (CKD). Few studies have addressed interventions to decrease …

Chronic kidney disease and pulse wave velocity: a narrative review

N Lioufas, CM Hawley, JD Cameron… - International journal …, 2019 - Wiley Online Library
Chronic kidney disease (CKD) is associated with excess cardiovascular mortality, resulting
from both traditional and nontraditional, CKD‐specific, cardiovascular risk factors …